Moreover, previous analysis of the TCGA database revealed that PARP10 expression is increased in 19% of breast tumors, and its overexpression facilitates cell proliferation and tumor progression (Khatib et al, 2022; Schleicher et al, 2018). Here, PARP10 is linked to breast neoplasm.